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P U B L I S H E D B Y E L S E V I E R I N C .LETTERS TO THE EDITORHigh-Intensity Plaques on Noncontrast
T1-Weighted Imaging as a Predictor
of Periprocedural Myocardial InjuryAlthough percutaneous coronary intervention (PCI)
routinely achieves good angiographic success, 5% to
30% of patients experience periprocedural myocar-
dial injury (pMI), which is associated with long-term
adverse outcomes and immediate adverse events
(1). Because coronary high-intensity plaques (HIPs)
detected by noncontrast T1-weighted imaging (T1WI)
represent plaque instability (2,3), we examined the
relationship between cardiac magnetic resonance
(CMR) characteristics of HIPs and pMI following elec-
tive PCI in patients with coronary artery disease (CAD).
Between October 2012 and March 2014, 57 patients
with CAD (mean age 68  11 years) underwent CMR
within 3 months (median 2 days; interquartile range
[IQR]: 1 to 24 days) of PCI. The plaque-to-myocardial
signal intensity ratio (PMR) was calculated (2,3).
pMI during PCI was deﬁned as an increase in serum
cardiac troponin T (cTnT) levels to more than 5 times
the upper limit of normal (0.07 ng/ml) at 24 h after PCI.
Intravascular ultrasound (IVUS) images were also ob-
tained. All patients were scannedwith a 3-TMR imager
(MAGNETOMVerio, Siemens AGHealthcare, Erlangen,
Germany) equipped with a 32-channel cardiac coil.
Plaque imaging (Figure 1A) was performed using an
inversion recovery prepared 3-dimensional T1W
turbo FLASH (fast low angle shot) sequence with
electrocardiogram-triggered, navigator-gated free
breathing and fat suppression in transaxial sections
covering the entire heart (inversion time 650 ms; ﬁeld
of view 280  228 mm; acquisition matrix 256  187;
reconstruction matrix 512  374; acquisition slice
thickness 1.0 mm; acquisition slice number 104 to 120;
reconstruction spatial resolution 0.6  0.5  0.6 mm;
fat suppression; effective repetition time/echo time
4.7 ms/2.13 ms; ﬂip angle 12; GRAPPA factor 2; navi-
gator gating window 1.5 to 2.5 mm; and data acqui-
sition window duration time 84 to 120 ms). The trigger
delay and acquisition window were set according to
the phase with minimal motion of the right coronary
artery as determined using cine MR imaging.
Clinical characteristics, cTnT levels at baseline,
target vessels, or type B2/C lesions were comparable
between the non-pMI (n ¼ 42) and pMI groups (n ¼ 15).
All lesions were treated with stent implantation.Transient slow or no reﬂow was observed signiﬁcantly
more frequently in patients with pMI than those
without (27% vs. 5%; p ¼ 0.036). Importantly, the me-
dian (IQR) of the PMR of PCI lesions was higher in pa-
tients with pMI than those without (1.3 [1.1 to 2.0] vs.
1.0 [0.8 to 1.2]; p ¼ 0.014) (Figure 1B). Receiver-
operating characteristic (ROC) analysis revealed that
the optimal PMR cutoff value for predicting pMIwas 1.3
and the area under the ROC curve was 0.71 (Figure 1C).
At this value, the sensitivity and speciﬁcity for pre-
dicting pMI were 67% and 86%, respectively. The
present cutoff value of PMR $1.3 for pMI is consistent
with our previous ﬁnding that PMR $1.4 predicts
future cardiac events (3). In the univariate logistic
regression analysis, PMR $1.3 (odds ratio [OR]: 12.0;
95% conﬁdence interval [CI]: 3.2 to 52.2; p < 0.001),
ultrasound attenuation (attenuation arc $180: OR:
6.1; 95% CI: 1.64 to 24.6; p ¼ 0.007), remodeling index
based on IVUS >1.05 (OR: 5.97; 95% CI: 1.54 to 29.2; p ¼
0.008), and total plaque area (OR: 0.88; 95% CI: 0.77 to
0.98; p¼0.021) were signiﬁcantly associatedwith pMI.
Although the etiology of pMI associated with PCI
is multifactorial, the predominant mechanism in-
volves distal embolization of plaque debris, intra-
luminal thrombus at the time of balloon inﬂation or
stent deployment, or both (1). As described herein,
noncontrast T1WI provided clinically and procedur-
ally important information on high-risk features of
coronary plaques without exposure to ionizing radi-
ation and contrast media. This less invasive, quanti-
tative technique may have an impact by identifying
individuals who are more likely to have periproce-
dural complications a priori and thereby change
therapeutic strategies.Yasuhide Asaumi, MD
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FIGURE 1 High-Intensity Plaques on Noncontrast T1-Weighted Imaging Predicts Periprocedural Myocardial Injury During
Percutaneous Coronary Intervention
(A) Representative cases of high-intensity plaques (HIPs) (a, b, c) and non-HIPs (d, e, f). A HIP (a, yellow arrow) and a non-HIP (d, yellow
arrow) are seen in the proximal left anterior descending (LAD) artery on noncontrast T1-weighted imaging, with a plaque-to-myocardial signal
intensity ratio (PMR) of 2.3 and 1.0, respectively. These lesions correspond to LAD plaques on computed tomography angiography (b and e,
yellow arrowheads) and coronary arteriography (c and f, yellow arrowheads). (B) Comparison of PMR between patients with and without
periprocedural myocardial injury (pMI). (C) Receiver-operating characteristic curve analysis for predicting pMI.
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989–99.Disagreement Between Different Deﬁnitions
of Coronary Artery Calcium ProgressionProgression of coronary artery calcium (CAC) as
measured by computed tomography independently
predicts coronary heart disease (CHD) events (1).
Several methods have been proposed to deﬁne and
quantify CAC progression yet very few studies have
compared different CAC progression deﬁnitions
(2,3). We sought to determine the concor-
dance between different CAC progression deﬁni-
tions and their association with traditional CHD risk
factors.
The Cooper Center Longitudinal study is a cohort
of >100,000 individuals referred for preventive
medical examination in Dallas, Texas. This report
includes 6,597 individuals (mean age 51.8 years,
22.8% female) who underwent serial cardiac com-
puted tomography scanning (Imatron C-150XP or
C-300, Siemens, Malvern, Pennsylvania) at least
9 months apart between the years of 1998 and
2006 (mean interval 2.9 years). Individuals with
previous CHD or coronary intervention between
scans were excluded. Participants provided informed
consent and the study was approved by the institu-
tional review board of the Cooper Institute. CAC
incidence (development of CAC in individuals with
baseline CAC ¼ 0) and CAC progression (increasing
CAC in individuals with baseline CAC > 0 in Agatston
units [AU]) were analyzed separately. Various pro-
gression deﬁnitions were applied as originally
described (2–4):
1. Continuous progression (annualized):
a. Absolute change: CACfollowup  CACbaseline
b. Log transformed change:
lnðCACfollowup þ 25Þ  lnðCACbaseline þ 25Þ
c. Square root transformed change:
OCACfollowup  OCACbaseline
d. Percentage of change:
½ðCACfollowup  CACbaselineÞ=CACbaseline  1002. Categorical progression:
a. Hokanson method:
ðOCACfollowup  OCACbaselineÞ >2:5
b. Raggi method: ½ðCACfollowup  CACbaselineÞ=
CACbaseline

>15%=year
c. Berry method:
For CAC >0 and # 100 AU:baseline
CACfollowup  CACbaseline

>10 AU=year
For CACbaseline >100 AU: ½ðCACfollowup
 CACbaseline

CACbaseline

>10%=yearprogression was also analyzed according to
only used risk categories (i.e., 0, >0 to <10, 10CAC
comm
to <100, 100 to <400, and $400 AU).
At baseline, 3,336 participants (50.6%) had CAC
scores of 0 and in this group, 520 (15.6%) had a positive
follow-up score. Among those with baseline CAC >0
(n ¼ 3,259), the median annualized change in CAC
was 17.7 AU [interquartile range: 32.4 to 67.8 AU].
Applying categorical methods, the binary classiﬁ-
cation of CAC progression was as follows: 44.2% pro-
gressed by Hokanson (45.7% in men, 33.0% women;
35.0% in baseline CAC <100 AU, 55.0% CAC $100 AU);
57.1% by Raggi (57.1% in men, 57.4% women; 67.8% in
baseline CAC<100 AU, 40.1% CAC$100 AU) and 52.5%
by Berry (53.8% in men, 43.1% women; 44.0% in
baseline CAC <100 AU, 62.3% CAC $100 AU). Cross-
tabulation between the most commonly referenced
methods, Hokanson and Raggi (2,3), revealed modest
concordance (70.5%) with a kappa coefﬁcient of 0.420.
Concordance estimates stratiﬁed by age, sex, and
baseline CAC score were: 70.1% for age #50 years,
70.4% age >50 years; 66.3% in women, 71.1% men;
66.7% for CAC <100 AU, 74.9% CAC $100 AU. When
stratiﬁed by risk categories, 27.9% moved to a higher
risk group, 0.7% moved to a lower risk group, and
71.4% remained in the same group.
Using logistic and linear regression models, the
predictors of CAC progression varied across different
deﬁnitions (Table 1). Notably, the annualized percent-
age of change method did not show consistent asso-
ciation with most well-established predictors of CHD.
The existing CAC progression deﬁnitions are based
on a variety of principles including interscan vari-
ability, observed relative changes from case-control
studies, and arbitrary yet logical constructs, so it is
not surprising that they result in divergent classiﬁca-
tion. There are no formal comparisons between dif-
ferent deﬁnitions of CAC progression related to CHD
events, just all-cause mortality (2). Though our study
is unable to identify a superior method, it does high-
light important limitations of deﬁnitions based on
